AKAP11杂合功能缺失突变对人iPSC衍生神经元的转录组与表观基因组影响
本研究利用全基因组方法,在人类iPSC衍生神经元中探究AKAP11杂合功能缺失突变对基因表达、DNA甲基化和组蛋白乙酰化修饰的影响。研究发现增强子异常活性参与转录失调,核糖体相关通路显著下调,该通路在双相障碍和精神分裂症死后脑组织及Akap11杂合敲除小鼠突触蛋白质组中同样改变。
要点
- AKAP11杂合LoF突变影响人神经元基因表达格局及DNA甲基化与组蛋白乙酰化修饰。
- 基因间区和内含子增强子异常活性参与转录失调,分别富集PBX2和NF1结合基序。
- 核糖体结构与功能相关通路显著下调,与BD和SCZ死后脑组织及小鼠突触蛋白组一致。
核心结论
- AKAP11单倍剂量不足通过增强子异常活性导致转录失调,并显著下调核糖体相关通路,为理解BD和SCZ的生物学根源提供线索。
研究设计与样本
- 研究采用全基因组方法,在人类诱导多能干细胞(iPSC)衍生的神经元中探究AKAP11杂合敲除后的转录组和染色质调控异常。
主要发现
- AKAP11杂合LoF突变影响基因表达格局,并改变DNA甲基化和组蛋白乙酰化修饰谱。
- 基因间区和内含子增强子异常活性分别富集PBX2和NF1已知结合基序,参与DNA结合转录因子活性、肌动蛋白结合与细胞骨架调控及细胞因子受体结合相关基因的转录失调。
- 核糖体结构与功能相关通路显著下调,该通路在BD和SCZ死后脑组织及Akap11杂合敲除小鼠突触蛋白质组中同样改变。
临床怎么用
- 本研究提示AKAP11单倍剂量不足可能通过增强子失调和核糖体通路下调参与BD和SCZ病理生理,为潜在治疗靶点提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The gene A-kinase anchoring protein 11 (AKAP11) recently emerged as a shared risk factor between bipolar disorder and schizophrenia, driven by large-effect loss-of-function (LoF) variants. Recent research has uncovered the neurophysiological characteristics and synapse proteomics profile of Akap11-mutant mouse models. Considering the role of AKAP11 in binding cAMP-dependent protein kinase A (PKA) and mediating phosphorylation of numerous substrates, such as transcription factors and epigenetic regulators, and given that chromatin alterations have been implicated in the brains of patients with bipolar disorder and schizophrenia, it is crucial to uncover the transcriptomic and chromatin dysregulations following the heterozygous knockout of AKAP11, particularly in human neurons. This study uses genome-wide approaches to investigate such aberrations in human induced pluripotent stem cell (iPSC)-derived neurons. We show the impact of heterozygous AKAP11 LoF mutations on the gene expression landscape and profile the DNA methylation and histone acetylation modifications. Altogether we highlight the involvement of aberrant activity of intergenic and intronic enhancers, which are enriched in PBX homeobox 2 (PBX2) and Nuclear Factor-1 (NF1) known binding motifs, respectively, in transcription dysregulations of genes mainly involved in DNA-binding transcription factor activity, actin binding and cytoskeleton regulation, and cytokine receptor binding. We also show significant downregulation of pathways related to ribosome structure and function, a pathway also altered in BD and SCZ post-mortem brain tissues and heterozygous Akap11-KO mice synapse proteomics. A better understanding of the dysregulations resulting from haploinsufficiency in AKAP11 improves our knowledge of the biological roots and pathophysiology of BD and SCZ, paving the way for better therapeutic approaches.
引用
- Farhangdoost N, Liao C, Liu Y, et al. Transcriptomic and epigenomic consequences of heterozygous loss-of-function mutations in AKAP11, a shared risk gene for bipolar disorder and schizophrenia. Mol Psychiatry. 2025. PMID: 40316678. doi:10.1038/s41380-025-03040-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。